Literature DB >> 31298652

Effects of Short-Term Fasting and Different Overfeeding Diets on Thyroid Hormones in Healthy Humans.

Alessio Basolo1, Brittany Begaye1, Tim Hollstein1, Karyne L Vinales1,2, Mary Walter3, Ferruccio Santini4, Jonathan Krakoff1, Paolo Piaggi1.   

Abstract

Background: A greater decrease in 24-hour energy expenditure (EE) during fasting and a smaller increase in 24-hour EE during low-protein overfeeding (metabolic "thrifty" phenotype) predict weight gain. As thyroid hormones (TH) are implicated in energy intake and metabolism, we assessed whether: (i) TH concentrations are altered by 24-hour fasting or overfeeding diets with varying protein content and (ii) diet-related changes in TH correlate with concomitant changes in EE.
Methods: Fifty-eight euthyroid healthy subjects with normal glucose regulation underwent 24-hour dietary interventions including fasting, eucaloric feeding, and five overfeeding diets in a crossover design within a whole-room indirect calorimeter to measure the 24-hour EE. Overfeeding diets (200% of energy requirements) included three diets with 20% protein, one diet with 3% protein (low-protein overfeeding diet [LPF]: 46% fat), and one diet with 30% protein (high-protein overfeeding diet [HPF]: 44% fat, n = 51). Plasma free thyroxine (fT4), free triiodothyronine (fT3), and fibroblast growth factor 21 (FGF21) concentrations were measured after overnight fast the morning of and after each diet.
Results: On average, fT4 increased by 8% (+0.10 ng/dL, 95% confidence interval [CI 0.07-0.13], p < 0.0001) and fT3 decreased by 6% (-0.17 pg/mL [CI -0.27 to -0.07], p = 0.001) after 24-hour fasting, whereas both fT4 and fT3 decreased by 5% (-0.07 ng/dL [CI -0.11 to -0.04], p < 0.0001) and 4% (-0.14 pg/mL [CI -0.24 to -0.04], p = 0.008) following HPF, respectively. Greater decreases in fT3 after HPF are associated with larger decreases in FGF21 (r = 0.40, p = 0.005). Following LPF, the mean fT3 increased by 6% (+0.14 pg/mL [CI 0.05-0.2], p = 0.003) with no change in fT4 (p = 0.7). No changes in TH were observed after normal-protein overfeeding diets (all p > 0.1). No associations were observed between TH concentrations and diet-related changes in 24-hour EE during any diet (all p > 0.07). Conclusions: Acute (200%) short-term (24 hours) changes in food intake induce small changes in TH concentrations only after diets with low (0% fasting and 3% protein overfeeding) or high (30% protein overfeeding) protein content. The fT3-FGF21 association after high-protein overfeeding suggests a role for TH in inhibiting FGF21 secretion by the liver during protein excess. These results indicate that TH are involved in protein metabolism; however, they do not mediate the short-term EE response to diets that characterize the metabolic phenotypes and determine the individual susceptibility to weight gain.

Entities:  

Keywords:  FGF21; energy expenditure; fasting; high-protein overfeeding; low-protein overfeeding; substrate oxidation; thyroid hormones

Year:  2019        PMID: 31298652      PMCID: PMC6864752          DOI: 10.1089/thy.2019.0237

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  66 in total

1.  The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue.

Authors:  L A de Jesus; S D Carvalho; M O Ribeiro; M Schneider; S W Kim; J W Harney; P R Larsen; A C Bianco
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Homeostatic regulation of protein intake: in search of a mechanism.

Authors:  Christopher D Morrison; Scott D Reed; Tara M Henagan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-08       Impact factor: 3.619

3.  Effect of caloric restriction and dietary composition of serum T3 and reverse T3 in man.

Authors:  S W Spaulding; I J Chopra; R S Sherwin; S S Lyall
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

Review 4.  Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate.

Authors:  Brian Kim
Journal:  Thyroid       Date:  2008-02       Impact factor: 6.568

5.  Decreased serum thyrotropin induced by fasting.

Authors:  M S Croxson; T D Hall; O A Kletzky; J E Jaramillo; J T Nicoloff
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

Review 6.  The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism.

Authors:  R Docter; E P Krenning; M de Jong; G Hennemann
Journal:  Clin Endocrinol (Oxf)       Date:  1993-11       Impact factor: 3.478

7.  Decreased free fraction of serum thyroid hormones during carbohydrate overfeeding.

Authors:  S Welle; M O'Connell; E Danforth; R Campbell
Journal:  Metabolism       Date:  1984-09       Impact factor: 8.694

8.  Nature of suppressed TSH secretion during undernutrition: effect of fasting and refeeding on TSH responses to prolonged TRH infusions.

Authors:  K D Burman; R C Smallridge; R Osburne; R C Dimond; N E Whorton; P Kesler; L Wartofsky
Journal:  Metabolism       Date:  1980-01       Impact factor: 8.694

9.  Investigations into the etiology of elevated serum T3 levels in protein-malnourished rats.

Authors:  R C Smallridge; A R Glass; L Wartofsky; K R Latham; K D Burman
Journal:  Metabolism       Date:  1982-06       Impact factor: 8.694

10.  Protein utilization in growth: effect of lysine deficiency on serum growth hormone, somatomedins, insulin, total thyroxine (T4) and triiodothyronine, free T4 index, and total corticosterone.

Authors:  T C Cree; D S Schalch
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

View more
  8 in total

1.  Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes.

Authors:  Tim Hollstein; Alessio Basolo; Takafumi Ando; Susanne B Votruba; Mary Walter; Jonathan Krakoff; Paolo Piaggi
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

2.  Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity.

Authors:  A Basolo; A M Poma; R Giannini; G Ceccarini; C Pelosini; P Fierabracci; M U Castany; S Bechi Genzano; C E Ambrosini; G Materazzi; L Chiovato; F Basolo; F Santini; L Torregrossa
Journal:  J Endocrinol Invest       Date:  2021-08-15       Impact factor: 4.256

3.  Meal-to-meal and day-to-day macronutrient variation in an ad libitum vending food paradigm.

Authors:  Tomás Cabeza de Baca; Paolo Piaggi; Marci E Gluck; Jonathan Krakoff; Susanne B Votruba
Journal:  Appetite       Date:  2022-01-21       Impact factor: 3.868

Review 4.  Ketogenic Diet and Weight Loss: Is There an Effect on Energy Expenditure?

Authors:  Alessio Basolo; Silvia Magno; Ferruccio Santini; Giovanni Ceccarini
Journal:  Nutrients       Date:  2022-04-26       Impact factor: 6.706

5.  Intermittent fasting for the prevention of cardiovascular disease.

Authors:  Mohammed Allaf; Hussein Elghazaly; Omer G Mohamed; Mohamed Firas Khan Fareen; Sadia Zaman; Abdul-Majeed Salmasi; Kostas Tsilidis; Abbas Dehghan
Journal:  Cochrane Database Syst Rev       Date:  2021-01-29

6.  Urinary Dopamine Excretion Rate Decreases during Acute Dietary Protein Deprivation and Is Associated with Increased Plasma Pancreatic Polypeptide Concentration.

Authors:  Alessio Basolo; Tim Hollstein; Mary Walter; Jonathan Krakoff; Paolo Piaggi
Journal:  Nutrients       Date:  2021-04-08       Impact factor: 5.717

7.  Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity.

Authors:  P Fierabracci; A Basolo; G Scartabelli; S Bechi Genzano; G Salvetti; G Sotgia; M Rotondi; L Chiovato; G Ceccarini; F Santini
Journal:  J Endocrinol Invest       Date:  2022-07-04       Impact factor: 5.467

8.  Free triiodothyronine (T3) is negatively associated with fasting ghrelin serum levels in a population sample of euthyroid subjects.

Authors:  D A Wittekind; J Kratzsch; R Mergl; R Baber; V Witte; A Villringer; M Kluge
Journal:  J Endocrinol Invest       Date:  2021-04-21       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.